Mercado de diagnóstico de precisión: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00029425
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 150
Buy Now

[Informe de investigación] Se proyecta que el mercado de diagnóstico de precisión alcanzará los 168.405,71 millones de dólares en 2028, desde los 79.776,88 millones de dólares de 2022; se espera que crezca a una tasa compuesta anual del 13,3 % entre 2022 y 2028.

Los diagnósticos de precisión son métodos de diagnóstico de enfermedades que explican la condición del paciente de manera detallada y precisa. Ayuda a los profesionales sanitarios a llevar a cabo procedimientos de tratamiento de forma eficaz y eficiente. Se utiliza para curar la diabetes, el cáncer y otros trastornos mediante diversas pruebas, incluidas pruebas esotéricas, pruebas genéticas y otras.

El mercado de diagnóstico de precisión está segmentado según el tipo, la aplicación, el usuario final, y geografía. Por geografía, el mercado está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el SAM El informe de mercado de diagnóstico de precisión ofrece información y un análisis en profundidad del mercado, enfatizando parámetros que incluyen el tamaño del mercado, las tendencias, los avances tecnológicos y la dinámica del mercado. También proporciona un análisis del panorama competitivo de los principales actores del mercado en todo el mundo. Además, el informe incluye el impacto de la pandemia de COVID-19 en el mercado de diagnóstico de precisión en todas las regiones.

Perspectivas estratégicas

El crecimiento del mercado de diagnóstico de precisión se atribuye a la Un número cada vez mayor de estudios en desarrollo para desarrollar un nuevo tratamiento contra el cáncer e iniciativas gubernamentales para crear conciencia sobre el diagnóstico de precisión entre los trabajadores de salud comunitarios. Sin embargo, el alto costo asociado con el diagnóstico y la medicina de precisión restringe el crecimiento del mercado.

regiones lucrativas para el mercado de diagnóstico de precisión

Perspectivas del mercado
Aplicación en aumento en oncología y otros trastornos impulsa el crecimiento del mercado de diagnóstico de precisión

El concepto de medicina de precisión se está aplicando con fuerza en el cuidado de enfermedades raras. Aunque es más popular en oncología, poco a poco se está extendiendo a otras especialidades. La creciente prevalencia del cáncer y la creciente incidencia de trastornos neurológicos raros están aumentando la demanda de medicina de precisión, lo que está impulsando el crecimiento del mercado mundial de diagnóstico de precisión. Además, según la Alianza Neurológica, en 2019 se registraron alrededor de 14,7 millones de casos neurológicos, y al menos 1 de cada 6 personas padecía una o más afecciones neurológicas. Según el Instituto Nacional del Cáncer, se prevé que el número de nuevos casos de cáncer aumente a 29,5 millones para 2040, y que las muertes relacionadas con el cáncer aumenten en 16,4 millones. Según la Organización Mundial de la Salud (OMS), la enfermedad de Alzheimer, la forma más común de demencia, contribuye a casi el 60-70% de los casos. Además, en septiembre de 2021, más de 55 millones de personas viven con demencia en todo el mundo, lo que representa casi 10 millones de casos nuevos al año. Además, la creciente demanda de procedimientos de tratamiento en oncología y otros trastornos está impulsando la adopción de procedimientos de tratamiento.

Además, el creciente número de colaboraciones estratégicas entre empresas biofarmacéuticas para desarrollar medicamentos destinados a tratar un grupo específico de pacientes en función de sus necesidades específicas y para proporcionar procedimientos y servicios de tratamiento eficaces está aumentando el número de ensayos clínicos. Por ejemplo, Personal Genome Diagnostics Inc. y el Hospital General de Massachusetts colaboraron para avanzar en el desarrollo de servicios de tratamiento eficaces en 2021. En abril de 2022, se forma el Precision Cancer Consortium (PCC) como una nueva colaboración de empresas farmacéuticas con una visión compartida de brindar pruebas integrales a todos los pacientes con cáncer en todo el mundo. Por lo tanto, la creciente aplicación en oncología y otros trastornos impulsa el crecimiento del mercado de diagnóstico de precisión.

Información basada en tipos

Según el tipo, el mercado de diagnóstico de precisión se segmenta en pruebas genéticas, pruebas esotéricas, y otros. En 2022, el segmento de pruebas genéticas tendrá la mayor cuota de mercado. Además, se espera que el mismo segmento registre la CAGR más alta del 13,8 % durante el período de pronóstico.

Mercado de diagnóstico de precisión, por tipo: 2022 y 2028

Información basada en aplicaciones

Según la aplicación, el mercado de diagnóstico de precisión se segmenta en oncología, cardiología, enfermedades respiratorias, inmunología y otros. .  El segmento de oncología tendrá la mayor cuota de mercado en 2022. Además, se prevé que el mismo segmento registre la tasa compuesta anual más alta del 13,8 % durante el período previsto.

Información basada en el usuario final

Según el usuario final, el mercado de diagnóstico de precisión se segmenta en laboratorios clínicos, hospitales, atención domiciliaria y otros. El segmento de laboratorios clínicos tiene la mayor cuota de mercado en 2022. Además, se prevé que el mismo segmento registre la CAGR más alta del 13,8% durante el período de pronóstico.

Los actores del mercado de diagnóstico de precisión se centran en adoptar estrategias orgánicas, incluido el lanzamiento y la expansión de productos, para ampliar su presencia y cartera de productos en todo el mundo y satisfacer las crecientes demandas.

Por geografía

Según la geografía, el mercado de diagnóstico de precisión está segmentado en América del Norte ( EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y el resto de Europa), Asia Pacífico (China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico) , Medio Oriente y Asia. África (Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y el resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y el resto de América Central y del Sur).

Perfiles de la empresa

  • Quest Diagnostics Incorporated
  • QIAGEN
  • Swiss Precision Diagnostics GmbH
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • Siemens Healthineers AG
  • Abbott
  • Novartis AG
  • Sanofi
  • Bayer AG
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is projected to be the fastest growing region in the global precision diagnostics market?

Asia Pacific is expected to be the fastest growing region in precision diagnostics market over the forecast period due to developing healthcare infrastructure, enormous population base, growing prevalence of chronic diseases, growing government efforts, and technological improvement in the sector.

Which region accounts for major market share in 2022 in global precision diagnostics market?

North America accounts for the major market share of precision diagnostics market in 2022 due to increasing prevalence of cancer and chronic cases in the region and increasing initiatives by government and companies operating in the country.

Which segment is dominating the precision diagnostics market based on type?

The colorectal cancer market is analyzed in the basis of type, application, and end user. Based on type, the market is segmented into genetic tests, esoteric tests, and others. The genetic tests segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR in the forecast period.

What are the growth estimates for the precision diagnostics market till 2028?

The precision diagnostics market is expected to be valued at US$ 168,405.71 million in 2028.

What is the estimated precision diagnostics market size of the market in 2022?

The precision diagnostics market is estimated to be valued at US$ 79,776.88 million in 2022.

What will be the CAGR of the precision diagnostics market during the forecast period?

The market is estimated to grow at a CAGR of 13.3% during the forecast period.

Who are the major players in precision diagnostics market across the globe?

The precision diagnostics market majorly consists of the players, such as Quest Diagnostics Incorporated; QIAGEN; Swiss Precision Diagnostics GmbH; Koninklijke Philips N.V.; Lantheus Medical Imaging, Inc.; Siemens Healthineers AG; Abbott; Novartis AG; Sanofi; and Bayer AG.

What are the driving factors for the global precision diagnostics market across the world?

The factors that are driving the growth of market are increasing demands of precision medicines and rising application of precision diagnostics. However, high investments involved in the R&D of precision medicine and diagnostic kits is the major factor hindering the precision diagnostics market growth.

What is precision diagnostics?

Precision diagnostics are disease diagnosis methods that explain the patient’s condition in a detailed and precise manner. It helps healthcare professionals to carry out treatment procedures in an effective and efficient manner. It is used to cure diabetes, cancer, and other disorders using various diagnostics tests.

The List of Companies - Precision Diagnostics Market

  1. Quest Diagnostics Incorporated
  2. QIAGEN
  3. Swiss Precision Diagnostics GmbH
  4. Koninklijke Philips N.V.
  5. Lantheus Medical Imaging, Inc.
  6. Siemens Healthineers AG
  7. Abbott
  8. Novartis AG
  9. Sanofi
  10. Bayer AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports